Exploring the "New Normal" for Monitoring in Decentralized Clinical Trials

The COVID-19 pandemic has suddenly accelerated the shift of incorporating virtual or remote elements into traditional clinical trials. For sponsors currently using remote monitoring practices or for those looking to incorporate remote services and technologies, how will they safeguard patient safety and ensure data quality in today's current environment? What can sponsors expect for the "new normal" going forward? Kristin Stallcup, Senior Director, Customer Success, and Vanesa Castillo, Executive Director, Central Monitoring Operations, recently shared their perspectives on the evolving trial landscape and the role of central monitoring and centralized risk management in both traditional and decentralized clinical trials.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/casestudies/Exploring-New-Normal-for-Monitoring-DCT-Case-Study-CSDCT002.pdf